Walkom: Ontario's phony war against druggists
Real health care cost drivers are the big multinational pharmaceuticals firms.
The Toronto Star's national affairs columnist Thomas Walkom wrote what one of the best analyses of the Ontario's government's battle controversial move to reduce subsidies to pharmacies for placement of generic drugs.
He calls the controversy a "sideshow." The move, he says, will save some money by removing "professional allowances" for generic drugs. "But the real cost drivers in health spending are the big multinational firms that make pharmaceuticals, not the druggists who sell them," he reports. The government's moves do nothing to curb the multinationals' power.
"Across the globe, drugs represent the fastest growing element of health-care costs. In part, that's because some drugs are remarkably useful. But in part it's because the handful of firms that create new drugs, protected in most of the world by robust patent laws, are able to sell at near-monopoly prices."...
For the full story, click here:
Posted: April 30, 2010
Public Values (PublicValues.ca) is a project of the Golden Lake Institute and the online publication StraightGoods.ca